Keyphrases
Inositol 1,4,5-trisphosphate Receptor (IP3R)
100%
T Cells
78%
Atrial Fibrillation
72%
Electrophysiologic
55%
Non-vitamin K Antagonist Oral Anticoagulants
50%
Catheterization Laboratory
50%
Reduced Dose
50%
Tyrosine Phosphorylation
50%
Practice Setting
50%
T Cell Receptor Signaling
50%
IP3 Receptor
50%
Glycoprotein IIb/IIIa Inhibitors
50%
Lipid-lowering
50%
Acute Coronary Syndrome
50%
Patients with Coronary Artery Disease
50%
Outcome Registry
50%
Relative Concentration
50%
Spontaneous Echo Contrast
50%
Red Blood Cells
50%
Fibrinogen
50%
Signal Averaging
50%
P-wave
50%
Cardioversion
50%
Inferior Vena Cava Filter
50%
Transfemoral Approach
50%
Electrical Remodeling
50%
Atrium
50%
Sinus Rhythm
50%
Signal-averaged Electrocardiogram
38%
Low-density Lipoprotein Cholesterol (LDL-C)
37%
Lipid Profile
37%
T Cell Antigen Receptor
28%
Ca2+
28%
Atrial Fibrillation Recurrence
27%
Lipid-lowering Medications
25%
Lipid Management
25%
Transfemoral
25%
Ca2+ Influx
21%
Washed Red Blood Cells
15%
Plasma Membrane
14%
Interleukin-2
14%
Total Population
12%
Academic Physician
12%
Medical Records
12%
Socioeconomic Differences
12%
Chart Review
12%
Coronary Artery Disease
12%
Drug Treatment
12%
Cardiology
12%
Medication Use
12%
Medicine and Dentistry
Inositol 1,4,5 Trisphosphate Receptor
100%
T Lymphocyte
55%
Glycoprotein IIb/IIIa Inhibitors
50%
Coronary Artery Disease
50%
Lymphocyte Structure
50%
Catheterization
50%
Platelet Glycoprotein
50%
T Lymphocyte Receptor
50%
Inferior Vena Cava Filter
50%
Acute Coronary Syndrome
50%
Calcium Ion
50%
Drug Therapy
50%
Protein Phosphorylation
50%
T Cell
48%
Receptor
40%
Carboxy Terminal Sequence
33%
Low Density Lipoprotein Cholesterol
30%
T Cell Activation
21%
Cardiology
20%
Venae cavae
16%
Radiofrequency Ablation
16%
Ryanodine Receptor
16%
Isotopes of Calcium
16%
Amino Terminal Sequence
16%
Intracellular Calcium
16%
Signal Transduction
16%
Messenger RNA
16%
Interleukin 2
15%
Antithrombotic Therapy
10%
Medical Record
10%
Thrombus
10%
Revascularization
10%
Antigen Specificity
10%
Cell Membrane
10%
Fibrinogen Receptor
10%
Sequela
10%
Tertiary Care
10%
Clinical Trial
10%
Heart Muscle Necrosis
10%
Cross Sectional Study
10%
Antithrombotic
10%
Antiplatelet Drug
10%
Hyperlipidemia
10%
Complementary DNA
5%
T-Cell Signaling
5%
Antisense
5%
T Cell Proliferation
5%
Receptor Expression
5%
Inositol 1,4,5 Trisphosphate
5%
Second Messenger
5%
